WHAT’S NEW? CQC EXEC JOINS CARE
TECHNOLOGY START-UP BIRDIE AXA-backed ‘agetech’ start-up Birdie has hired the former Executive Director of Strategy & Intelligence of Care Quality Commission, Dr. Malte Gerhold, to develop its offering of integrated health and social care for older adults.
Dr. Malte Gerhhold
Birdie is a venture that endeavours to innovate the elderly care sector and improve the lives of a million older adults
in five years. As Chief Integrated Care Officer, Dr. Gerhold will support the management team in spearheading and executing a proactive and person-centred integrated care model for older adults.
Prior to his role at Birdie, Dr Gerhold worked for six years at the CQC and was responsible for setting out the organisation’s five- year strategy. He was an advisor at the Prime Minister’s Delivery Unit before being appointed Deputy Director of the Strategy Unit at the Department of Health. Earlier in his career, he spent some time in Sierra Leone, advising the government on its delivery priorities including health, energy and private sector investment.
FUJIFILM OFFERS WALES PREVIEW OF NEW GLOBAL TECH
Since its foundation in 2017, thousands of carers now work with Birdie’s solution to drive the standards of care up by being more transparent, person-centred and proactive in the management of client health and wellbeing to ensure quality of life and peace of mind. Dr Gerhold’s appointment is set to optimise the impact of this approach further, with his mandate to build a more integrated care offering across the care path journey of older adults.
Dr Gerhold commented: “Aſter more than six fantastic years, I have decided to leave CQC to seek a very different challenge. In CQC’s State of Care report this year, we talked about the importance and opportunity of new technologies and different ways of working for people requiring care, based on their needs. I’m excited to be able to make a direct contribution to that in the future.”
Commenting on the appointment, Max Parmentier, CEO of Birdie, said: “Malte shares Birdie’s vision to help older adults live happier and healthier lives in the comfort of their own home. He combines an exceptional track-record with strong leadership, and has the critical skillset to help us develop a fully integrative approach in improving the way care providers deliver care to our ever-growing ageing population.”
www.birdie.care
Thanks to the AI, cases where abnormalities have been identified in a patient will be prioritised and immediately referred to a radiologist for assessment, speeding up diagnosis and treatment.
The technology uses deep learning algorithms to provide a clear visual and statistical analysis of a wide range of conditions.
L-R - Adrian Waller, General Manager at Fujifilm Medical Systems UK, with Yoshitaka Nakamura, Managing Director of Fujifilm UK & Ireland, and Cari-Anne Quinn, CEO of Life Sciences Hub Wales
Global tech giant Fujifilm has given Welsh healthcare professionals an exclusive first look at its latest medical innovation, ahead of the product’s global clinical launch.
The Japanese multinational photography and imaging company, which is a pioneer in medical imaging and diagnostics equipment, previewed its new artificial intelligence (AI) soſtware at an event hosted by Life Sciences Hub Wales.
The FDR nano is a mobile X-ray unit that uses integrated AI technology to quickly identify and flag abnormalities that need further investigation. The product is the first Fujifilm AI- enabled mobile unit in Europe and is due to commence clinical trials in a UK hospital next month.
The AI in the unit highlights suspicious areas on an image to the radiographer, taking the X-ray using a heat map. This means that any potential issues are detected and flagged at the time of the X-ray examination and, instead of being sent to a radiologist’s workflow list without prioritisation, can be flagged for immediate attention.
twitter.com/TomorrowsCare
Adrian Waller, General Manager at Fujifilm UK Ireland, said: "By flagging abnormalities straight away, this new technology can ensure cases are effectively prioritised and put at the top of the list for reporting, which in turn will speed up diagnosis and treatment for patients.”
The technology was unveiled at the first Life Sciences Hub Wales ‘Industry Technology Day’ – an event designed to give clinicians and healthcare professionals early access to medical technology. The Life Sciences Hub works to bring together and support collaboration between industry, health and social care, and research organisations to make a positive difference to the health and wellbeing of people in Wales.
Fujifilm will be exhibiting its healthcare technology at the Tomorrow’s Health 2020 conference, organised by Life Sciences Hub Wales, on Wednesday 25th
and Thursday 26th
March in Llandudno. The conference will include interactive sessions, workshops, and exhibitions, as well as talks from world-leading experts.
Tickets to the inaugural event are complimentary with limited spaces available. To register your place or for more information visit:
http://tomorrowshealth.wales - 13 -
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
